{"nct_id":"NCT03573817","title":"A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD","status":"COMPLETED","status_verified_date":"2022-02","start_date":"2018-05-31","start_date_type":"ACTUAL","primary_completion_date":"2018-09-25","primary_completion_date_type":"ACTUAL","completion_date":"2018-09-25","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["VTRS"]}